Wubin Pan
Founder presso CONNECT BIOPHARMA HOLDINGS LIMITED
Patrimonio netto: 11 M $ in data 31/03/2024
Profilo
Wu Bin Pan is the founder of Crown Bioscience International (founded in 2006), Crown Bioscience, Inc. (founded in 2006), Suzhou Connect Biopharma Co. Ltd.
(founded in 2012), and Connect Biopharma Holdings Ltd.
(founded in 2012).
He held the position of Chief Operating Officer, EVP & China President at Crown Bioscience, Inc. from 2006 to 2011.
He is currently a Director at Connect Biopharma HongKong Ltd.
Dr. Pan was previously a Principal at Terragen Discovery, Inc. and Vice President at Shenzhen Yuanxing Biomedical Technology Co., Ltd.
(from 2000 to 2006).
Dr. Pan received a doctorate degree from the University of Sussex in 1994, an MBA degree from Tsinghua University in 2010, and an undergraduate degree from Sun Yat-Sen University in 1985.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2023 | 6 197 398 ( 11.25% ) | 11 M $ | 31/03/2024 |
Posizioni attive di Wubin Pan
| Società | Posizione | Inizio |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Founder | 01/05/2012 |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Founder | 02/05/2012 |
| Connect Biopharma HongKong Ltd. | Director/Board Member | - |
Precedenti posizioni note di Wubin Pan
| Società | Posizione | Fine |
|---|---|---|
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Founder | 01/10/2011 |
| CROWN BIOSCIENCE INTERNATIONAL | Founder | 01/10/2011 |
Shenzhen Yuanxing Biomedical Technology Co., Ltd.
 Shenzhen Yuanxing Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Tsinghua Yuanxing Biotechnology, Inc. is engaged in the development of biological and pharmaceutical products. It is involved in the research and development, commercialization of adenoviral vector vaccine. The company was founded on December 4, 2000 and is headquartered in Shenzhen, China. | Corporate Officer/Principal | 01/05/2006 |
Terragen Discovery, Inc.
 Terragen Discovery, Inc. Pharmaceuticals: MajorHealth Technology Part of Cubist Pharmaceuticals LLC, Terragen Discovery, Inc. is a developer of antibiotics and patent drugs. The private company is based in Vancouver, Canada. Terragen Discovery was acquired by Cubist Pharmaceuticals LLC on October 26, 2000 for $25.61 million. | Corporate Officer/Principal | - |
Formazione di Wubin Pan
| University of Sussex | Doctorate Degree |
| Tsinghua University | Masters Business Admin |
| Sun Yat-Sen University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Aziende private | 6 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Terragen Discovery, Inc.
Terragen Discovery, Inc. Pharmaceuticals: MajorHealth Technology Part of Cubist Pharmaceuticals LLC, Terragen Discovery, Inc. is a developer of antibiotics and patent drugs. The private company is based in Vancouver, Canada. Terragen Discovery was acquired by Cubist Pharmaceuticals LLC on October 26, 2000 for $25.61 million. | Health Technology |
Shenzhen Yuanxing Biomedical Technology Co., Ltd.
Shenzhen Yuanxing Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Tsinghua Yuanxing Biotechnology, Inc. is engaged in the development of biological and pharmaceutical products. It is involved in the research and development, commercialization of adenoviral vector vaccine. The company was founded on December 4, 2000 and is headquartered in Shenzhen, China. | Health Technology |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Health Technology |
| Connect Biopharma HongKong Ltd. |
- Borsa valori
- Insiders
- Wubin Pan
